Plasma-Lyte A SODIUM CHLORIDE SODIUM GLUCONATE SODIUM ACETATE POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE BAXTER HEALTHCARE COMPANY FDA Approved No description available yet.
FunFoxMeds bottle
Substance Magnesium Chloride
Route
INTRAVENOUS

Drug Facts

Composition & Profile

Quantities
1000 ml 100 ml 9 container

Identifiers & Packaging

Container Type BOTTLE
UNII
02F3473H9O 660YQ98I10 4550K0SC9B 451W47IQ8X R6Q3791S76
Packaging

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Container Label JB2544 1000 mL DIN 02339358 PLASMA-LYTE A INJECTION PLASMA-LYTE A, Injectable Norme Baxter Std APPROX mmol/L Na – 140 K – 5 Mg – 1.5 Cl – 98 ACETATE – 27 GLUCONATE – 23 mOsmol/L – 294 pH 7.4 INTRAVENOUS FLUID AND ELECTROLYTE REPLENISHMENT RETABLISSEMENT HYDRO-ELECTROLYTIQUE PAR INJECTION INTRAVEINEUSE PER 100 mL SODIUM CHLORIDE USP – 526 mg / SODIUM GLUCONATE - 502 mg / SODIUM ACETATE TRIHYDRATE USP – 368 mg / POTASSIUM CHLORIDE USP – 37 mg / MAGNESIUM CHLORIDE HEXAHYDRATE USP – 30 mg / WATER FOR INJECTION USP – qs pH MAY BE ADJUSTED WITH SODIUM HYDROXIDE PAR 100 mL CHLORURE DE SODIUM USP – 526 mg / GLUCONATE DE SODIUM - 502 mg / ACETATE DE SODIUM TRIHYDRATE USP – 368 mg CHLORURE DE POTASSIUM USP – 37 mg / CHLORURE DE MAGNESIUM HEXAHYDRATE USP – 30 mg / EAU POUR INJECTION USP – qs LE pH AJUSTE AVEC L’HYDROXYDE DE SODIUM CAUTIONS SINGLE USE / DISCARD UNUSED PORTION / SQUEEZE AND INSPECT BAG / SEE DIRECTIONS FOR USE / MUST NOT BE USED IN SERIES CONNECTIONS / STORE AT 15°C TO 25°C ATTENTIONS USAGE UNIQUE / JETER PORTION INUTILISEE/ PRESSER ET INSPECTER LE SAC / VOIR MODE D’EMPLOI / NE DOIT PAS ETRE MONTE EN SERIE / GARDER ENTRE ET 15°C ET 25°C NONPYROGENIC / STERILE / APYROGENE VIAFLEX PVC CONTAINER / CONTENANT DE PVC BAXTER PLASMA-LYTE AND VIAFLEX ARE TRADEMARKS OF BAXTER INTERNATIONAL INC BAXTER PLASMA-LYTE ET VIAFLEX SONT DES MARQUES DE COMMERCE DE BAXTER INTERNATIONAL INC Baxter Logo Baxter Corporation Mississauga ON L5C 0C2 No LATEX Label 07-25-77-284 1 _ 2 _ 3 _ 4 _ 5 _ 6 _ 7 _ 8 _ 9 Container Label 0338-9591-01

Package Descriptions
  • PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Container Label JB2544 1000 mL DIN 02339358 PLASMA-LYTE A INJECTION PLASMA-LYTE A, Injectable Norme Baxter Std APPROX mmol/L Na – 140 K – 5 Mg – 1.5 Cl – 98 ACETATE – 27 GLUCONATE – 23 mOsmol/L – 294 pH 7.4 INTRAVENOUS FLUID AND ELECTROLYTE REPLENISHMENT RETABLISSEMENT HYDRO-ELECTROLYTIQUE PAR INJECTION INTRAVEINEUSE PER 100 mL SODIUM CHLORIDE USP – 526 mg / SODIUM GLUCONATE - 502 mg / SODIUM ACETATE TRIHYDRATE USP – 368 mg / POTASSIUM CHLORIDE USP – 37 mg / MAGNESIUM CHLORIDE HEXAHYDRATE USP – 30 mg / WATER FOR INJECTION USP – qs pH MAY BE ADJUSTED WITH SODIUM HYDROXIDE PAR 100 mL CHLORURE DE SODIUM USP – 526 mg / GLUCONATE DE SODIUM - 502 mg / ACETATE DE SODIUM TRIHYDRATE USP – 368 mg CHLORURE DE POTASSIUM USP – 37 mg / CHLORURE DE MAGNESIUM HEXAHYDRATE USP – 30 mg / EAU POUR INJECTION USP – qs LE pH AJUSTE AVEC L’HYDROXYDE DE SODIUM CAUTIONS SINGLE USE / DISCARD UNUSED PORTION / SQUEEZE AND INSPECT BAG / SEE DIRECTIONS FOR USE / MUST NOT BE USED IN SERIES CONNECTIONS / STORE AT 15°C TO 25°C ATTENTIONS USAGE UNIQUE / JETER PORTION INUTILISEE/ PRESSER ET INSPECTER LE SAC / VOIR MODE D’EMPLOI / NE DOIT PAS ETRE MONTE EN SERIE / GARDER ENTRE ET 15°C ET 25°C NONPYROGENIC / STERILE / APYROGENE VIAFLEX PVC CONTAINER / CONTENANT DE PVC BAXTER PLASMA-LYTE AND VIAFLEX ARE TRADEMARKS OF BAXTER INTERNATIONAL INC BAXTER PLASMA-LYTE ET VIAFLEX SONT DES MARQUES DE COMMERCE DE BAXTER INTERNATIONAL INC Baxter Logo Baxter Corporation Mississauga ON L5C 0C2 No LATEX Label 07-25-77-284 1 _ 2 _ 3 _ 4 _ 5 _ 6 _ 7 _ 8 _ 9 Container Label 0338-9591-01